Overview
Description
Genelink Inc. is a biotechnology company specializing in molecular genetics products and services, with a focus on supplying custom oligonucleotides—including ultra-modified RNA, DNA, and chimeric oligos—to research institutions, pharmaceutical companies, and hospitals. The company’s portfolio includes a range of genetic research tools such as fluorescently labeled probes, genetic detection reagents, DNA purification kits, and specialized probes used for advanced molecular biology applications. Genelink also offers 12-gene DNA assessment services, alongside customized health supplements and a dedicated line of skin care products tailored to genetic profiles. Its technologies are applied in genetic disorder detection—particularly in triple repeat disorders like fragile X syndrome, Huntington’s disease, and myotonic dystrophy—and are designed to support scientific research, diagnostics, and personalized wellness. By integrating proprietary DNA assessment with consumer health products, Genelink plays a unique dual role in both the research and personal genomics sectors, driving innovation at the intersection of genetics, healthcare, and wellness solutions.
About
CEO
Employees
0
Address
8240 Exchange Drive
Suite C1
Orlando, 32809, FL
United States
Suite C1
Orlando, 32809, FL
United States
Phone
407-680-1150
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
PINX